Active multiple sclerosis lesions show inflammatory changes suggestive of a combined attack by autoreactive T and B lymphocytes against brain white matter. These pathogenic immune cells derive from progenitors that are normal, innocuous components of the healthy immune repertoire but become autoaggressive upon pathological activation. The stimuli triggering this autoimmune conversion have been commonly attributed to environmental factors, in particular microbial infection. However, using the relapsing-remitting mouse model of spontaneously developing experimental autoimmune encephalomyelitis, here we show that the commensal gut flora-in the absence of pathogenic agents-is essential in triggering immune processes, leading to a relapsing-remitting autoimmune disease driven by myelin-specific CD4(+) T cells. We show further that recruitment and activation of autoantibody-producing B cells from the endogenous immune repertoire depends on availability of the target autoantigen, myelin oligodendrocyte glycoprotein (MOG), and commensal microbiota. Our observations identify a sequence of events triggering organ-specific autoimmune disease and these processes may offer novel therapeutic targets.
There is emerging evidence that the commensal microbiota has a role in the pathogenesis of multiple sclerosis (MS), a putative autoimmune disease of the CNS. Here, we compared the gut microbial composition of 34 monozygotic twin pairs discordant for MS. While there were no major differences in the overall microbial profiles, we found a significant increase in some taxa such as Akkermansia in untreated MS twins. Furthermore, most notably, when transplanted to a transgenic mouse model of spontaneous brain autoimmunity, MS twin-derived microbiota induced a significantly higher incidence of autoimmunity than the healthy twin-derived microbiota. The microbial profiles of the colonized mice showed a high intraindividual and remarkable temporal stability with several differences, including Sutterella, an organism shown to induce a protective immunoregulatory profile in vitro. Immune cells from mouse recipients of MS-twin samples produced less IL-10 than immune cells from mice colonized with healthy-twin samples. IL-10 may have a regulatory role in spontaneous CNS autoimmunity, as neutralization of the cytokine in mice colonized with healthy-twin fecal samples increased disease incidence. These findings provide evidence that MS-derived microbiota contain factors that precipitate an MS-like autoimmune disease in a transgenic mouse model. They hence encourage the detailed search for protective and pathogenic microbial components in human MS.
SummaryThe transfer of antigens from oligodendrocytes to immune cells has been implicated in the pathogenesis of autoimmune diseases. Here, we show that oligodendrocytes secrete small membrane vesicles called exosomes, which are specifically and efficiently taken up by microglia both in vitro and in vivo. Internalisation of exosomes occurs by a macropinocytotic mechanism without inducing a concomitant inflammatory response. After stimulation of microglia with interferon-, we observe an upregulation of MHC class II in a subpopulation of microglia. However, exosomes are preferentially internalised in microglia that do not seem to have antigenpresenting capacity. We propose that the constitutive macropinocytotic clearance of exosomes by a subset of microglia represents an important mechanism through which microglia participate in the degradation of oligodendroglial membrane in an immunologically 'silent' manner. By designating the capacity for macropinocytosis and antigen presentation to distinct cells, degradation and immune function might be assigned to different subtypes of microglia. Journal of Cell Sciencethrough which microglia participate in the degradation of oligodendroglial membrane. Results Internalisation of oligodendroglia-derived exosomes by microgliaTo obtain exosomes in large quantities, we isolated exosomes from the culture medium of the mouse oligodendroglial precursor cell line Oli-neu. Sequential centrifugation steps with increasing centrifugal forces up to 100,000 g yielded a pellet, which we have previously shown to contain small membrane vesicles with a diameter of about 50-100 nm (Trajkovic et al., 2008). Further analysis of the 100,000 g pellet with continuous sucrose density gradients revealed that PLP and myelin oligodendrocyte glycoprotein (MOG) are recovered from fractions with the characteristic density of exosomes that contain the exosomal marker proteins Alix (ALG-2-interacting protein 1), TSG101 and flotillin-2 (Fig. 1A). Hence, we refer to the 100,000 g membrane fractions as exosomes.To follow the fate of exosomes, suspensions of purified exosomes were labelled with the dye PKH67 and added to primary cultures of mouse oligodendrocytes, cortical neurons, astrocytes and microglia. After incubating the exosomes for 2 hours at 37°C, cells were fixed and analysed by confocal microscopy. We observed efficient internalisation of exosomes by microglia, whereas uptake by astrocytes, neurons or oligodendrocytes was almost absent (Fig. 1B). By confocal microscopy, we confirmed that exosomes were inside microglia rather than attached to the cell surface. In addition, we observed that exosomes colocalised with Lamp1, a marker for late endosomes or lysosomes, verifying that exosomes had been endocytosed and transported to endosomal organelles ( Fig. 2A). When exosomes were added to mixed brain cultures that contained all major glial cell types, we again observed that exosomes were almost exclusively internalised by Iba-1-positive microglia (supplementary material Fig. S1). Similar results wer...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.